These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18784433)

  • 21. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
    Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
    Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.
    Hartmann O; Spyratos F; Harbeck N; Dietrich D; Fassbender A; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Lerebours F; Welzel K; Maier S; Plum A; Niemann S; Foekens JA; Lesche R; Martens JW
    Clin Cancer Res; 2009 Jan; 15(1):315-23. PubMed ID: 19118060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.
    Katsaros D; Cho W; Singal R; Fracchioli S; Rigault De La Longrais IA; Arisio R; Massobrio M; Smith M; Zheng W; Glass J; Yu H
    Gynecol Oncol; 2004 Sep; 94(3):685-92. PubMed ID: 15350359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
    Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
    Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA hypermethylation in breast cancer and its association with clinicopathological features.
    Li S; Rong M; Iacopetta B
    Cancer Lett; 2006 Jun; 237(2):272-80. PubMed ID: 16029926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
    Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
    Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.
    Winter SL; Bosnoyan-Collins L; Pinnaduwage D; Andrulis IL
    BMC Cancer; 2007 May; 7():85. PubMed ID: 17511879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients.
    Taback B; Giuliano AE; Lai R; Hansen N; Singer FR; Pantel K; Hoon DS
    Ann N Y Acad Sci; 2006 Sep; 1075():211-21. PubMed ID: 17108214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between frequent CpG island methylation and HER2 amplification in human breast cancers.
    Terada K; Okochi-Takada E; Akashi-Tanaka S; Miyamoto K; Taniyama K; Tsuda H; Asada K; Kaminishi M; Ushijima T
    Carcinogenesis; 2009 Mar; 30(3):466-71. PubMed ID: 19168584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [5'CpG island methylation of the suppressor gene p16/CDKN2/MTS1 in renal carcinoma].
    Maestro ML; Del Barco V; Sanz-Casla MT; Moreno J; Zanna I; Redondo E; Fernández C; Resel L
    Arch Esp Urol; 2000 Jun; 53(5):417-23. PubMed ID: 10961005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.
    Fiegl H; Jones A; Hauser-Kronberger C; Hutarew G; Reitsamer R; Jones RL; Dowsett M; Mueller-Holzner E; Windbichler G; Daxenbichler G; Goebel G; Ensinger C; Jacobs I; Widschwendter M
    Clin Cancer Res; 2008 Jun; 14(11):3494-502. PubMed ID: 18519782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between serum DNA methylation and prognosis in gastric cancer patients.
    Ikoma H; Ichikawa D; Koike H; Ikoma D; Tani N; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H
    Anticancer Res; 2006; 26(3B):2313-6. PubMed ID: 16821608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of HuR in hereditary breast cancer.
    Heinonen M; Fagerholm R; Aaltonen K; Kilpivaara O; Aittomäki K; Blomqvist C; Heikkilä P; Haglund C; Nevanlinna H; Ristimäki A
    Clin Cancer Res; 2007 Dec; 13(23):6959-63. PubMed ID: 18056170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer.
    Ikoma H; Ichikawa D; Daito I; Nobuyuki T; Koike H; Okamoto K; Ochiai T; Ueda Y; Yamagishi H; Otsuji E
    Hepatogastroenterology; 2007; 54(75):946-50. PubMed ID: 17591100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.